EW logo

Edwards Lifesciences (EW) Selling, general & administrative expenses

annual SGA:

$1.79B-$35.40M(-1.94%)
December 31, 2024

Summary

  • As of today (June 22, 2025), EW annual SGA is $1.79 billion, with the most recent change of -$35.40 million (-1.94%) on December 31, 2024.
  • During the last 3 years, EW annual SGA has risen by +$295.50 million (+19.78%).
  • EW annual SGA is now -1.94% below its all-time high of $1.82 billion, reached on December 31, 2023.

Performance

EW SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWincome statement metrics

quarterly SGA:

$465.70M-$26.20M(-5.33%)
March 1, 2025

Summary

  • As of today (June 22, 2025), EW quarterly SGA is $465.70 million, with the most recent change of -$26.20 million (-5.33%) on March 1, 2025.
  • Over the past year, EW quarterly SGA has dropped by -$24.00 million (-4.90%).
  • EW quarterly SGA is now -5.33% below its all-time high of $491.90 million, reached on December 31, 2024.

Performance

EW quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWincome statement metrics

TTM SGA:

$49.18B+$4.18B(+9.29%)
March 1, 2025

Summary

  • As of today (June 22, 2025), EW TTM SGA is $49.18 billion, with the most recent change of +$4.18 billion (+9.29%) on March 1, 2025.
  • Over the past year, EW TTM SGA has increased by +$47.49 billion (+2795.56%).
  • EW TTM SGA is now at all-time high.

Performance

EW TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

EW Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-1.9%-4.9%+2795.6%
3 y3 years+19.8%+25.8%+3107.9%
5 y5 years+44.0%+51.3%+3773.7%

EW Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-1.9%+19.8%-5.3%+131.7%at high+108.1%
5 y5-year-1.9%+45.6%-5.3%+131.7%at high+240.6%
alltimeall time-1.9%+781.4%-5.3%+903.7%at high>+9999.0%

EW Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Mar 2025
-
$465.70M(-5.3%)
$1.83B(-1.3%)
Dec 2024
$1.79B(-1.9%)
$491.90M(+16.7%)
$1.85B(+4.2%)
Sep 2024
-
$421.40M(-6.5%)
$1.78B(+2.3%)
Jun 2024
-
$450.80M(-7.9%)
$1.74B(+2.4%)
Mar 2024
-
$489.70M(+17.5%)
$1.70B(+3.2%)
Dec 2023
$1.82B(+16.4%)
$416.60M(+9.1%)
$1.65B(+15.1%)
Sep 2023
-
$381.90M(-6.9%)
$1.43B(+0.3%)
Jun 2023
-
$410.40M(-5.9%)
$1.43B(+0.1%)
Mar 2023
-
$436.30M(+117.1%)
$1.42B(+4.9%)
Dec 2022
$1.57B(+4.9%)
$201.00M(-46.7%)
$1.36B(-14.1%)
Sep 2022
-
$377.30M(-7.8%)
$1.58B(+0.8%)
Jun 2022
-
$409.00M(+10.5%)
$1.57B(+2.3%)
Mar 2022
-
$370.30M(-12.7%)
$1.53B(+2.6%)
Dec 2021
$1.49B(+21.6%)
$424.00M(+16.4%)
$1.49B(+6.1%)
Sep 2021
-
$364.40M(-2.7%)
$1.41B(+4.2%)
Jun 2021
-
$374.50M(+13.2%)
$1.35B(+8.0%)
Mar 2021
-
$330.80M(-2.3%)
$1.25B(+1.9%)
Dec 2020
$1.23B(-1.1%)
$338.50M(+10.2%)
$1.23B(-0.7%)
Sep 2020
-
$307.20M(+11.7%)
$1.24B(+0.1%)
Jun 2020
-
$274.90M(-10.7%)
$1.24B(-2.6%)
Mar 2020
-
$307.80M(-11.3%)
$1.27B(+2.2%)
Dec 2019
$1.24B(+14.1%)
$347.20M(+13.4%)
$1.24B(+5.0%)
Sep 2019
-
$306.20M(-0.7%)
$1.18B(+3.2%)
Jun 2019
-
$308.50M(+10.1%)
$1.15B(+3.0%)
Mar 2019
-
$280.30M(-2.7%)
$1.11B(+2.2%)
Dec 2018
$1.09B(+9.9%)
$288.10M(+6.9%)
$1.09B(+1.4%)
Sep 2018
-
$269.50M(-2.0%)
$1.07B(+2.4%)
Jun 2018
-
$274.90M(+7.4%)
$1.05B(+3.1%)
Mar 2018
-
$256.00M(-6.2%)
$1.02B(+2.7%)
Dec 2017
$990.80M(+9.5%)
$272.80M(+11.5%)
$990.80M(+4.1%)
Sep 2017
-
$244.60M(+0.3%)
$951.60M(+1.6%)
Jun 2017
-
$243.80M(+6.2%)
$936.60M(+1.6%)
Mar 2017
-
$229.60M(-1.7%)
$921.60M(+1.9%)
Dec 2016
$904.70M(+6.3%)
$233.60M(+1.7%)
$904.70M(+1.3%)
Sep 2016
-
$229.60M(+0.3%)
$893.40M(+2.0%)
Jun 2016
-
$228.80M(+7.6%)
$875.80M(+1.7%)
Mar 2016
-
$212.70M(-4.3%)
$860.90M(+1.2%)
Dec 2015
$850.70M(-0.9%)
$222.30M(+4.9%)
$850.70M(-0.1%)
Sep 2015
-
$212.00M(-0.9%)
$851.50M(-1.2%)
Jun 2015
-
$213.90M(+5.6%)
$861.70M(-0.2%)
Mar 2015
-
$202.50M(-9.2%)
$863.30M(+0.6%)
Dec 2014
$858.00M(+17.0%)
$223.10M(+0.4%)
$858.00M(+4.4%)
Sep 2014
-
$222.20M(+3.1%)
$821.50M(+5.7%)
Jun 2014
-
$215.50M(+9.3%)
$777.10M(+3.9%)
Mar 2014
-
$197.20M(+5.7%)
$748.20M(+2.0%)
Dec 2013
$733.40M(+5.2%)
$186.60M(+4.9%)
$733.40M(+2.3%)
Sep 2013
-
$177.80M(-4.7%)
$716.80M(+1.4%)
Jun 2013
-
$186.60M(+2.3%)
$706.80M(+0.6%)
Mar 2013
-
$182.40M(+7.3%)
$702.60M(+0.7%)
Dec 2012
$697.40M
$170.00M(+1.3%)
$697.40M(+1.0%)
Sep 2012
-
$167.80M(-8.0%)
$690.80M(+0.3%)
DateAnnualQuarterlyTTM
Jun 2012
-
$182.40M(+2.9%)
$688.50M(+2.9%)
Mar 2012
-
$177.20M(+8.4%)
$669.30M(+4.2%)
Dec 2011
$642.40M(+16.8%)
$163.40M(-1.3%)
$642.40M(+3.4%)
Sep 2011
-
$165.50M(+1.4%)
$621.40M(+5.5%)
Jun 2011
-
$163.20M(+8.6%)
$588.90M(+4.0%)
Mar 2011
-
$150.30M(+5.5%)
$566.30M(+3.0%)
Dec 2010
$550.00M(+8.1%)
$142.40M(+7.1%)
$550.00M(+1.9%)
Sep 2010
-
$133.00M(-5.4%)
$539.90M(+1.3%)
Jun 2010
-
$140.60M(+4.9%)
$533.00M(+2.3%)
Mar 2010
-
$134.00M(+1.3%)
$520.90M(+2.4%)
Dec 2009
$508.80M(+5.9%)
$132.30M(+4.9%)
$508.80M(+2.4%)
Sep 2009
-
$126.10M(-1.9%)
$496.70M(+1.4%)
Jun 2009
-
$128.50M(+5.4%)
$489.90M(+0.4%)
Mar 2009
-
$121.90M(+1.4%)
$487.90M(+1.5%)
Dec 2008
$480.60M(+15.0%)
$120.20M(+0.8%)
$480.60M(+1.2%)
Sep 2008
-
$119.30M(-5.7%)
$474.90M(+3.5%)
Jun 2008
-
$126.50M(+10.4%)
$458.80M(+5.7%)
Mar 2008
-
$114.60M(+0.1%)
$434.00M(+3.8%)
Dec 2007
$418.00M(+11.2%)
$114.50M(+10.9%)
$418.00M(+4.9%)
Sep 2007
-
$103.20M(+1.5%)
$398.60M(+3.0%)
Jun 2007
-
$101.70M(+3.1%)
$387.10M(+1.2%)
Mar 2007
-
$98.60M(+3.7%)
$382.40M(+1.8%)
Dec 2006
$376.00M(+7.7%)
$95.10M(+3.7%)
$375.80M(+2.1%)
Sep 2006
-
$91.70M(-5.5%)
$368.10M(+1.6%)
Jun 2006
-
$97.00M(+5.4%)
$362.30M(+1.9%)
Mar 2006
-
$92.00M(+5.3%)
$355.40M(+1.8%)
Dec 2005
$349.00M(+9.1%)
$87.40M(+1.7%)
$349.00M(+1.4%)
Sep 2005
-
$85.90M(-4.7%)
$344.30M(+1.8%)
Jun 2005
-
$90.10M(+5.3%)
$338.10M(+2.8%)
Mar 2005
-
$85.60M(+3.5%)
$329.00M(+2.8%)
Dec 2004
$319.90M(+10.3%)
$82.70M(+3.8%)
$319.90M(+3.4%)
Sep 2004
-
$79.70M(-1.6%)
$309.40M(+3.1%)
Jun 2004
-
$81.00M(+5.9%)
$300.20M(+1.8%)
Mar 2004
-
$76.50M(+6.0%)
$295.00M(+1.8%)
Dec 2003
$289.90M(+27.2%)
$72.20M(+2.4%)
$289.90M(+1.2%)
Sep 2003
-
$70.50M(-7.0%)
$286.40M(+6.0%)
Jun 2003
-
$75.80M(+6.2%)
$270.10M(+8.6%)
Mar 2003
-
$71.40M(+3.9%)
$248.60M(+9.1%)
Dec 2002
$227.90M(+12.3%)
$68.70M(+26.8%)
$227.90M(+8.9%)
Sep 2002
-
$54.20M(-0.2%)
$209.30M(+3.9%)
Jun 2002
-
$54.30M(+7.1%)
$201.50M(+0.8%)
Mar 2002
-
$50.70M(+1.2%)
$199.90M(-1.5%)
Dec 2001
$203.00M(-6.0%)
$50.10M(+8.0%)
$203.00M(-3.6%)
Sep 2001
-
$46.40M(-12.0%)
$210.50M(-0.1%)
Jun 2001
-
$52.70M(-2.0%)
$210.70M(-2.9%)
Mar 2001
-
$53.80M(-6.6%)
$217.00M(-2.8%)
Dec 2000
$216.00M(-7.3%)
$57.60M(+23.6%)
$223.20M(+34.8%)
Sep 2000
-
$46.60M(-21.0%)
$165.60M(+39.2%)
Jun 2000
-
$59.00M(-1.7%)
$119.00M(+98.3%)
Mar 2000
-
$60.00M
$60.00M
Dec 1999
$233.00M
-
-

FAQ

  • What is Edwards Lifesciences annual SGA?
  • What is the all time high annual SGA for Edwards Lifesciences?
  • What is Edwards Lifesciences annual SGA year-on-year change?
  • What is Edwards Lifesciences quarterly SGA?
  • What is the all time high quarterly SGA for Edwards Lifesciences?
  • What is Edwards Lifesciences quarterly SGA year-on-year change?
  • What is Edwards Lifesciences TTM SGA?
  • What is the all time high TTM SGA for Edwards Lifesciences?
  • What is Edwards Lifesciences TTM SGA year-on-year change?

What is Edwards Lifesciences annual SGA?

The current annual SGA of EW is $1.79B

What is the all time high annual SGA for Edwards Lifesciences?

Edwards Lifesciences all-time high annual SGA is $1.82B

What is Edwards Lifesciences annual SGA year-on-year change?

Over the past year, EW annual SGA has changed by -$35.40M (-1.94%)

What is Edwards Lifesciences quarterly SGA?

The current quarterly SGA of EW is $465.70M

What is the all time high quarterly SGA for Edwards Lifesciences?

Edwards Lifesciences all-time high quarterly SGA is $491.90M

What is Edwards Lifesciences quarterly SGA year-on-year change?

Over the past year, EW quarterly SGA has changed by -$24.00M (-4.90%)

What is Edwards Lifesciences TTM SGA?

The current TTM SGA of EW is $49.18B

What is the all time high TTM SGA for Edwards Lifesciences?

Edwards Lifesciences all-time high TTM SGA is $49.18B

What is Edwards Lifesciences TTM SGA year-on-year change?

Over the past year, EW TTM SGA has changed by +$47.49B (+2795.56%)
On this page